Assignee profile:

ZymoGenetics, Inc.

City:

Princeton, New Jersey

Country:

United States

Published Applications:

46

Last publication date:

2020-04-30

Patent Grants:

37

Last grant date:

2019-10-08

Top Inventors for applications by ZymoGenetics, Inc.

These are the the leading inventors for applications assigned to ZymoGenetics, Inc.:

Recent patent applications by ZymoGenetics, Inc.

ZymoGenetics, Inc. based in Princeton, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-04-30
US20200131245A1
Chemistry; metallurgy

TREATING INFLAMMATION WITH SOLUBLE HYBRID FCGAMMA RECEPTORS

#2 | 2019-02-07 ✅ Patent 10,434,173 granted on 2019-10-08
US20190038743A1
Human necessities

Use of IL-31 monoclonal antibodies for treating pruritus

#3 | 2018-10-25 ✅ Patent 10,640,559 granted on 2020-05-05
US20180305448A1
Chemistry; metallurgy

Nucleic acid molecules encoding humanized IL-31 monoclonal antibodies

#4 | 2018-10-04 ✅ Patent 10,640,575 granted on 2020-05-05
US20180282433A1
Chemistry; metallurgy

Use of IL-17A and IL-17F cross-reactive monoclonal antibodies for treating inflammatory diseases

#5 | 2018-09-06 ✅ Patent 10,562,967 granted on 2020-02-18
US20180251541A1
Chemistry; metallurgy

Treating inflammation with IL-17/IL-23 bispecific antibodies

#6 | 2018-08-30 ✅ Patent 10,611,846 granted on 2020-04-07
US20180244790A1
Chemistry; metallurgy

Methods of treating skin disorders using anti-IL-31RA antibodies

#7 | 2018-06-07
US20180155418A1
Chemistry; metallurgy

IL-31 ANTIBODY COMPOSITIONS

#8 | 2017-12-14 ✅ Patent 10,273,297 granted on 2019-04-30
US20170355763A1
Chemistry; metallurgy

Use of IL-31 monoclonal antibodies for reducing pruritus

#9 | 2017-11-09 ✅ Patent 10,227,415 granted on 2019-03-12
US20170320931A1
Chemistry; metallurgy

Methods of producing a zcytor17 heterodimeric cytokine receptor

#10 | 2017-08-10 ✅ Patent 10,570,187 granted on 2020-02-25
US20170226184A1
Chemistry; metallurgy

Soluble hybrid Fcγ receptors and related methods

#11 | 2017-07-27
US20170209542A1
Human necessities

HOMOGENEOUS PREPARATIONS OF IL-28 AND IL-29

#12 | 2017-07-06 ✅ Patent 9,828,431 granted on 2017-11-28
US20170190780A1
Chemistry; metallurgy

Use of IL-31RA monoclonal antibodies for treating neuronal inflammation

#13 | 2017-07-06 ✅ Patent 9,834,602 granted on 2017-12-05
US20170190771A1
Chemistry; metallurgy

Use of IL-31 monoclonal antibodies for treating neuronal inflammation

#14 | 2017-06-29 ✅ Patent 9,878,038 granted on 2018-01-30
US20170182160A1
Human necessities

Methods of treating atopic dermatitis with IL-31 monoclonal antibodies

#15 | 2017-02-16 ✅ Patent 9,683,037 granted on 2017-06-20
US20170044253A1
Chemistry; metallurgy

Method of treating atopic dermatitis with IL-31 monoclonal antibodies

#16 | 2016-10-27 ✅ Patent 9,708,390 granted on 2017-07-18
US20160311909A1
Chemistry; metallurgy

Compositions and methods for inhibiting PDGFRbeta and VEGF-A

#17 | 2015-12-24 ✅ Patent 9,512,219 granted on 2016-12-06
US20150368336A1
Chemistry; metallurgy

IL-31 monoclonal antibodies

#18 | 2015-07-02 ✅ Patent 9,416,184 granted on 2016-08-16
US20150183868A1
Chemistry; metallurgy

Method of treating pruritus with IL-31 monoclonal antibodies

#19 | 2015-06-25 ✅ Patent 10,005,837 granted on 2018-06-26
US20150175702A1
Chemistry; metallurgy

B7 family member zB7H6 and related compositions and methods

#20 | 2015-05-14 ✅ Patent 9,334,322 granted on 2016-05-10
US20150132300A1
Chemistry; metallurgy

Methods of antagonizing signal transduction in spinal cord cells using an IL-31Ra or OSMR-b antagonist

#21 | 2015-05-14 ✅ Patent 9,334,321 granted on 2016-05-10
US20150132299A1
Chemistry; metallurgy

Methods of treating neuronal inflammation using an IL-31 monoclonal antibody

#22 | 2015-02-05
US20150037331A1
Chemistry; metallurgy

IL-31 MONOCLONAL ANTIBODIES

#23 | 2015-01-08 ✅ Patent 9,416,183 granted on 2016-08-16
US20150010553A1
Chemistry; metallurgy

Methods of treating inflammatory diseases using antibodies that bind both IL-17A and IL-17F

#24 | 2014-09-04
US20140248661A1
Chemistry; metallurgy

ZCYTOR19 POLYNUCLEOTIDES, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE

#25 | 2014-07-03 ✅ Patent 9,005,921 granted on 2015-04-14
US20140186891A1
Chemistry; metallurgy

Polynucleotides encoding IL-31 monoclonal antibodies

#26 | 2014-07-03 ✅ Patent 8,974,783 granted on 2015-03-10
US20140186346A1
Chemistry; metallurgy

Methods of treating pain using an IL-31Ra or OSMR-b antagonist

#27 | 2014-06-26 ✅ Patent 9,499,598 granted on 2016-11-22
US20140178333A1
Chemistry; metallurgy

Mutants of IL-29

#28 | 2014-05-22 ✅ Patent 9,212,213 granted on 2015-12-15
US20140141485A1
Chemistry; metallurgy

ZCYTOR17 heterodimeric cytokine receptor

#29 | 2014-05-08 ✅ Patent 8,968,732 granted on 2015-03-03
US20140127206A1
Chemistry; metallurgy

Methods of treating pain using an IL-31 monoclonal antibody

#30 | 2014-04-17 ✅ Patent 9,663,566 granted on 2017-05-30
US20140107034A1
Chemistry; metallurgy

Soluble hybrid Fcγ receptors and related methods

#31 | 2014-03-20 ✅ Patent 9,156,909 granted on 2015-10-13
US20140080181A1
Chemistry; metallurgy

Polynucleotides encoding IL-31 monoclonal antibodies

#32 | 2014-02-13
US20140044676A1
Chemistry; metallurgy

USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS

#33 | 2013-11-21 ✅ Patent 8,992,922 granted on 2015-03-31
US20130309235A1
Chemistry; metallurgy

Antagonists of IL-17A, IL-17F, and IL-23P19

#34 | 2013-11-14
US20130302795A1
Chemistry; metallurgy

CYTOKINE ZALPHA11 LIGAND

#35 | 2013-10-10 ✅ Patent 9,011,858 granted on 2015-04-21
US20130266562A1
Chemistry; metallurgy

Variable region sequences of IL-31 monoclonal antibodies and methods of use

#36 | 2013-08-15
US20130209470A1
Chemistry; metallurgy

ANTIBODIES THAT BIND BOTH IL-17A AND IL-17F AND METHODS OF USING THE SAME

#37 | 2013-08-08 ✅ Patent 8,926,957 granted on 2015-01-06
US20130203070A1
Physics

Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells

#38 | 2013-08-01 ✅ Patent 8,685,395 granted on 2014-04-01
US20130195855A1
Human necessities

Methods of antagonizing signal transduction in dorsal root ganglion cells

#39 | 2013-07-11
US20130177563A1
Human necessities

METHODS OF TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLS

#40 | 2013-06-06 ✅ Patent 8,647,866 granted on 2014-02-11
US20130143265A1
Chemistry; metallurgy

ZCYTOR17 heterodimeric cytokine receptor polynucleotides

#41 | 2013-04-18 ✅ Patent 8,822,642 granted on 2014-09-02
US20130095102A1
Chemistry; metallurgy

Dimeric fusion proteins and related compositions and methods

#42 | 2013-02-14 ✅ Patent 8,648,182 granted on 2014-02-11
US20130041143A1
Chemistry; metallurgy

Polynucleotides encoding antibodies to cytokine receptor zcytor17

#43 | 2011-07-21 ✅ Patent 9,441,034 granted on 2016-09-13
US20110177074A1
Chemistry; metallurgy

Compositions and methods for inhibiting PDGFRβ and VEGF-A

#44 | 2011-04-07 ✅ Patent 8,969,518 granted on 2015-03-03
US20110081346A1
Chemistry; metallurgy

B7 family member zB7H6 and related compositions and methods

#45 | 2008-12-18 ✅ Patent 8,071,090 granted on 2011-12-06
US20080311104A1
Human necessities

Stabilized thrombin compositions

#46 | 2008-11-27 ✅ Patent 8,062,876 granted on 2011-11-22
US20080293122A1
Chemistry; metallurgy

Method for activating prethrombin-1

Also check out ZymoGenetics, Inc.'s (Princeton, United States) applicant profile with 55 patent applications submitted.

AssigneeID:

9638 ⎘